Yameng Sun
Welcome,         Profile    Billing    Logout  
 5 Trials 
9 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
You, Hong
NCT05450887: Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary Cholangitis

Completed
3
108
RoW
Obeticholic Acid Tablets(OCA), UDCA, Placebo
Nanjing Chia-tai Tianqing Pharmaceutical
Primary Biliary Cholangitis
03/24
04/24
NCT05193916: A Phase II Clinical Trial of Chiglitazar for NASH

Completed
2
104
RoW
chiglitazar sodium tablets, Bilessglu®, CS-038, Carfloglitazar, Placebo, simulant of chiglitazar
Chipscreen Biosciences, Ltd.
NASH
01/24
01/24
B-UNITED, NCT06537414: A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)

Recruiting
2
280
Europe, Canada, Japan, US, RoW
Daplusiran/Tomligisiran Dose Level 1, Daplusiran/Tomligisiran Dose Level 2, Bepirovirsen, Placebo
GlaxoSmithKline
Chronic Hepatitis B Virus Infection, Hepatitis B
10/27
10/27
NCT05786963: Comparison of Hepatus and FibroScan for Evaluation of Fibrosis and Steatosis

Recruiting
N/A
400
RoW
Beijing Friendship Hospital
Chronic Hepatitis b, Non-Alcoholic Fatty Liver Disease
12/23
04/24
NCT06795646: Clinical Classification of MAFLD Based Liver Biopsy

Not yet recruiting
N/A
2000
RoW
Beijing Friendship Hospital, Fudan University, Tianjin Second People's Hospital, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, The Affiliated Hospital of Hangzhou Normal University, Ruijin Hospital
Metabolic Dysfunction Associated Steatotic Liver Disease, Metabolic Dysfunction-associated Steatohepatitis (MASH)
12/28
12/38
NCT03777969: Prediction System of Clinical Endpoint Events for Chronic Hepatitis B Patients

Active, not recruiting
N/A
2000
RoW
Beijing Friendship Hospital, Nanfang Hospital of Southern Medical University, Ruijin Hospital, ShuGuang Hospital, Beijing Ditan Hospital, Hangzhou Choutu Technology Co.,Ltd., Wuxi Hisky Medical Technologies Co., Ltd.
Chronic Hepatitis b
12/28
12/28
FHCS, NCT05546086: BeijngFH Health Cohort Study

Recruiting
N/A
8103
RoW
Beijing Friendship Hospital, Chinese Academy of Medical Sciences
Non-Alcoholic Fatty Liver Disease
04/32
04/32
NCT05086536: Re-compensation and Its Clinical Characteristics in HBV Decompensated Cirrhosis

Not yet recruiting
N/A
600
RoW
no intervention
Beijing Friendship Hospital, Beijing YouAn Hospital, Shandong Provincial Hospital, The Affiliated Hospital of Qingdao University, The First Affiliated Hospital of Shanxi Medical University, Xiangya Hospital of Central South University, The Second Affiliated Hospital of Baotou Medical College
Hepatitis B, Decompensated Cirrhosis
06/22
12/22
Chen, Shuyan
NCT05786963: Comparison of Hepatus and FibroScan for Evaluation of Fibrosis and Steatosis

Recruiting
N/A
400
RoW
Beijing Friendship Hospital
Chronic Hepatitis b, Non-Alcoholic Fatty Liver Disease
12/23
04/24

Download Options